[ad_1]
The respiratory care company is firing on all cylinders.
Lewis Gradon, Managing Director and CEO of FPH.
Listed respiratory healthcare company Fisher & Paykel Healthcare has provided guidance for the first half of fiscal 2025 after a strong year-to-date performance across all products and regions.
The company expects revenue to grow 18% to $940 million to $950 million in the first half of 2025
Want to read more? It’s easy.
Choose the best value subscription option
personal
Group Members
NBR Market
Annual Premium Online Subscription
NZ$499.00 / year
Monthly Premium Online Subscription
NZD 44.95 per month
Smartphone subscription only
NZD 24.95/month
Premium Group Membership 10 users
NZD 350+ Goods and Services Tax / Monthly
$35 per user – payable monthly by credit or debit card
Premium Group Membership 20 users
NZD 600+ Goods and Services Tax / Monthly
$30 per user – payable monthly by credit or debit card
Premium Group Membership 50 users
NZD 1250+ Goods and Services Tax / Monthly
$25 per user – payable monthly by credit or debit card
Premium Group Membership 100 users
NZD 1875+ Goods and Services Tax / Monthly
$18.75 per user – payable monthly via credit or debit card
Annual Premium Online Subscription + NBR Marketplace
NZ$499.00 / year
Already have an account? Log in
© All content is copyrighted by NBR. No reproduction in any form is permitted without permission, even if you have a paid subscription.
[ad_2]
Source link
